Ubrelvy
My Prescription
Payment
Select pharmacy
$1,680.96
$30.00 due at pharmacy
$1,680.96 - $30.00 = $1,650.96
$1,650.96 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
WalmartPowered by$1,680.96
Print or send this coupon to your phone
WalmartPowered byPay as little as $0 for Ubrelvy
Works with your insurance. Enroll in the manufacturer's savings program in a few steps.
About Ubrelvy
Drug Details
Ubrelvy (ubrogepant) is a medication designed to treat sudden migraine attacks in adults, whether accompanied by aura or not. It operates by blocking the calcitonin gene-related peptide (CGRP) receptors in the brain. This action helps to alleviate headache pain and reduce symptoms such as nausea, vomiting, and sensitivity to light and sound. By effectively preventing the effects of CGRP, Ubrelvy (ubrogepant) reduces inflammation and pain associated with migraines, enabling a quicker return to normal activities and potentially decreasing the need for additional pain relief medications. It is important to note that Ubrelvy is not intended for the prevention of future migraines or reducing their frequency. Dosage may vary (50 mg or 100 mg) based on individual response, kidney or liver health, or interactions with other medications. Some side effects may include nausea, sleepiness, and dry mouth. Always consult with a healthcare professional before starting any new medication to ensure it is safe and appropriate for your condition.
Price history for Ubrelvy
16 Tablets, 100MG
Average retail price for Ubrelvy
Average SaveHealth price for Ubrelvy
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Ubrelvy dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 50MG | 1 Tablet | $111.75 | $111.75 |
| 50MG | 10 Tablets | $1,072.47 | $107.25 |
| 100MG | 16 Tablets | $1,680.96 | $105.06 |
| 100MG | 1 Tablet | $109.75 | $109.75 |
| 100MG | 10 Tablets | $1,052.48 | $105.25 |
Ubrelvy FAQs
Ubrelvy (ubrogepant) is considered an effective medication for the acute treatment of migraine attacks in adults. It works by blocking the CGRP receptor, which is involved in migraine pathophysiology. Clinical studies have shown that it can help reduce migraine pain and associated symptoms. However, its effectiveness can vary from person to person, and it is important to consult with a healthcare provider to determine if it is suitable for an individual's specific condition and medical history.
The effectiveness of Ubrelvy (ubrogepant) versus Imitrex (sumatriptan) can vary depending on the individual and the specific characteristics of their migraine. Ubrelvy is a newer medication that works as a CGRP receptor antagonist, while Imitrex is a triptan that works by narrowing blood vessels around the brain. Some patients may find Ubrelvy more effective or better tolerated, especially if they experience side effects with triptans or have cardiovascular concerns. Others may respond better to Imitrex. It is important for patients to consult with their healthcare provider to determine which medication is more suitable for their specific needs.
Ubrelvy is classified as a calcitonin gene-related peptide (CGRP) receptor antagonist. It is used for the acute treatment of migraine with or without aura in adults.
Ubrelvy (ubrogepant) is considered effective for the acute treatment of migraine attacks. Clinical studies have shown that it can help reduce migraine pain and other associated symptoms, such as nausea and sensitivity to light and sound, within two hours of taking the medication. Its effectiveness can vary among individuals, but many patients experience significant relief. It is important for patients to follow their healthcare provider's instructions and discuss any concerns or side effects they may experience.
Imitrex (sumatriptan) and Ubrelvy (ubrogepant) are both medications used to treat migraines, but they work differently. Imitrex is a triptan, which works by stimulating serotonin receptors to constrict blood vessels and reduce inflammation. It is typically used to treat acute migraine attacks. Ubrelvy, on the other hand, is a CGRP receptor antagonist, which works by blocking the calcitonin gene-related peptide involved in migraine attacks. Unlike Imitrex, Ubrelvy does not cause vasoconstriction, making it a suitable option for patients who cannot use triptans due to cardiovascular concerns.